Aclarion, Inc.
Aclarion, Inc.
Your view on ACONW
Overview
What the company does, where it operates, and who runs it.
About Aclarion, Inc.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Brent Ness
- Headquarters
- 8181 Arista Place, Broomfield, CA, US
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Brent Ness
- Headquarters
- 8181 Arista Place, Broomfield, CA, US
Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite.
This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021.
Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Aclarion, Inc. from FRC's valuation model, read against the market price. ACONW last traded at $0.02; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Aclarion, Inc.. Starting points for Aclarion, Inc.: EPS -$3.64, beta 1.21 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Aclarion, Inc.. Aclarion, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Aclarion, Inc.. Trailing twelve-month EPS for Aclarion, Inc. stands at -$3.64. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | -$1.16 | -$1.51 | -$4.74 | -$3.06 |
| Low estimate | -$1.16 | -$1.51 | -$4.95 | -$3.19 |
| High estimate | -$1.16 | -$1.51 | -$4.53 | -$2.93 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | -$3.60 | -$1.34 | -$13.611 | — |
| Growth | +67.8% | -12.7% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $31559.00 | $40000.00 | $109467.00 | $233365.00 |
| Low estimate | $31559.00 | $40000.00 | $105821.00 | $222124.00 |
| High estimate | $31559.00 | $40000.00 | $113115.00 | $244615.00 |
| No. of analysts | 1 | 1 | 1 | 2 |
| Year-ago revenue | $18479.00 | $21140.00 | $75730.00 | — |
| Growth | +70.8% | +89.2% | +44.5% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Aclarion, Inc.. Aclarion, Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- APYIAspyra Inc.Medical - Healthcare Information Services$34
- BBLNFBabylon Holdings LimitedMedical - Healthcare Information Services$2,561
- ETAOFETAO International Co., Ltd.Medical - Care Facilities$2,049
- FDBHFounders Bay HoldingsInformation Technology Services$15,022
- MDXLMediXall Group, Inc.Medical - Healthcare Information Services$20,551
- NHELNatural Health Farm Holdings Inc.Medical - Healthcare Information Services$16,219
More Medical - Healthcare Information Services companies
- PINCPremier, Inc.CBOE$2.3B
- PKY.AXPathkey.AI LtdASX
- PMCUFPro Medicus LimitedOTC$8.4B
- PME.AXPro Medicus LimitedASX
- PPJEPPJ Healthcare Enterprises, Inc.OTC$890,484
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Aclarion, Inc., and how their positions are changing. At a $10,933 market value, institutional positions materially move Aclarion, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Aclarion, Inc. executives and directors. Shares of Aclarion, Inc. have traded between $0.02 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Aclarion, Inc.. Coverage tracks Aclarion, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Aclarion, Inc.